Al Tamimi & Company Advises Dubai Investments Industries on Full Acquisition of Clemenceau Medical Centre Dubai

Dubai, UAE – 29 July 2026 – Al Tamimi & Company has advised Dubai Investments Industries LLC (DII), a wholly owned subsidiary of Dubai Investments PJSC, on its acquisition of the remaining shares in Clemenceau Medical Centre FZ-LLC (CMC Dubai), resulting in DII becoming the sole shareholder of one of Dubai Healthcare City’s leading private hospitals.

Dubai Investments PJSC is a leading UAE-based investment company, incorporated in 1995, with a diversified portfolio spanning real estate, healthcare, building materials, investments and services.

The transaction marks a significant milestone for DII, strengthening its position in the UAE’s healthcare sector and providing a platform to further expand CMC Dubai’s specialist healthcare services and support its long-term growth strategy.

Al Tamimi & Company’s Corporate team acted as lead legal counsel throughout the transaction, advising on all aspects of the acquisition, including the negotiation of multiple share purchase agreements, regulatory requirements within Dubai Healthcare City, financing-related arrangements, intellectual property licensing, and the restructuring of legacy shareholder and management arrangements.

The matter required close coordination across several practice areas and involved managing multiple interdependent workstreams under an accelerated timetable. Lawyers from the firm’s Corporate, Banking & Finance, Real Estate, Intellectual Property and Regulatory teams worked together to deliver a seamless, commercially focused solution for the client. Throughout the transaction, the Al Tamimi team worked under the instruction and close coordination of Antoine Abi Rached (GCC) and the wider Dubai Investments team, whose support and guidance were instrumental in enabling the matter to progress efficiently to completion.

Commenting on the transaction, Alyzeh Zahid, Of Counsel, Corporate at Al Tamimi & Company said:

“We are delighted to have supported Dubai Investments Industries on this strategically important acquisition. The transaction demonstrates our ability to manage sophisticated, multi-party M&A transactions involving complex regulatory, financing and commercial considerations while maintaining a clear focus on our client’s strategic objectives. It also highlights the strength of our integrated, cross-practice approach to delivering seamless legal advice on high-value transactions in the UAE’s regulated sectors. We would also like to thank Antoine Abi Rached, DI Group General Counsel,  and the Dubai Investments team for their instruction, close coordination and support throughout the transaction.”

The Al Tamimi & Company team was led by Richard Catling and Alyzeh Zahid, with support from Jeanne Visser, Zeenah Awamleh, Ehab Morcos, Mohamed Nazmy, Mariam Eldawy, Omar AlJuneidi, Mohammed Kawasmi, Edward Imrie, Adnan Zuwayyed, Mariam Sabet and Emma Rubidge.

This mandate further reinforces Al Tamimi & Company’s position as a leading legal adviser on complex mergers and acquisitions and strategic investments across the healthcare sector and the wider Middle East.